Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration

Journal of Neurology

Volumn 252, Issue 2, 2005, Pages 197-201

  Frings, Markus ^a   Antoch, Gerald ^a   Knorn, Philipp ^a   Freudenberg, Lutz ^a   Bier, Ulrich ^a   Timmann, Dagmar ^a   Maschke, Matthias ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Anti Yo; Paraneoplastic cerebellar degeneration; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TUMOR MARKER;

ADENOCARCINOMA; ADULT; ANATOMY; ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MICROSCOPY; NEEDLE BIOPSY; NEUROLOGIC DISEASE; OVARIECTOMY; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC SYNDROME; PELVIS TUMOR; PEROPERATIVE CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

ADENOCARCINOMA; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PARANEOPLASTIC CEREBELLAR DEGENERATION; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; WHOLE-BODY COUNTING;

EID: 15244340294     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-005-0635-0     Document Type: Article

References (17)

1. Anderson NE, Rosenblum MK, Posner JB (1988) Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 24:559-567
2. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, Bockisch A, Debatin JF, Freudenberg LS (2003) Non-Small Cell Lung Cancer: Dual-Modality PET/CT in Preoperative Staging. Radiology 229:526-533
3. 18F] fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Ann Neurol 48:105-108
4. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, Altman H, Keidar Z, Israel O (2003) Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 44:1200-1209
5. 18F]FDG-PET. Q J Nucl Med 47:85-89
6. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R (2000) A combined PET-CT scanner for clinical oncology. J Nucl Med 41:1369-1379
7. Grisold W, Drlicek M, Liszka-Setinek U, Wondrusch E (1995) Anti-tumour therapy in paraneoplastic neurological disease. Clin Neurol Neurosurg 97: 106-111
8. Keime-Guibert F, Graus F, Fleury A, Rene R, Honnorat J, Broet P, Delattre JY (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 68:479-482
9. Peterson K, Rosenblum MK, Kotanides H, Posner JB (1992) Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42:1931-1937
10. Posner JB (1995) Paraneoplastic syndromes. In: Posner JB (ed) Neurologic complications of cancer. FA, Davis, Philadelphia, pp 353-385
11. 18F]fluoro-2-deoxy-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain 124:2223-2231
12. Rojas I, Graus F, Keime-Guibert F, Rene R, Delattre JY, Ramon JM, Dalmau J, Posner JB (2000) Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 55:713-715
13. Shams'ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, Vecht C, Sillevis Smitt P (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126: 1409-1418
14. Shinohara Y, Ohnuki Y, Yoshii F, Takahashi W, Onoe K, Takagi S (1998) Detection of primary tumor in paraneoplastic cerebellar degeneration by FDG-PET. Ann Neurol 43:684
15. Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC, Massaquoi S, Gomez CM, Coutinho P, Ben Hamida M, Campanella G, Filla A, Schut L, Timmann D, Honnorat J, Nighoghossian N, Manyam B (1997) International Cooperative Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 145:205-211
16. Voltz R (2002) Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 1:294-305
17. Widdess-Walsh P, Tavee JO, Schuele S, Stevens GH (2003) Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature. J Neurooncol 63:187-190